X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19370) 19370
Book Review (4983) 4983
Newsletter (1251) 1251
Publication (1095) 1095
Newspaper Article (260) 260
Book Chapter (150) 150
Book / eBook (116) 116
Magazine Article (96) 96
Conference Proceeding (65) 65
Trade Publication Article (25) 25
Dissertation (16) 16
Transcript (7) 7
Reference (6) 6
Data Set (3) 3
Web Resource (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16286) 16286
humans (13361) 13361
male (8568) 8568
diabetes (7095) 7095
female (6473) 6473
animals (5470) 5470
middle aged (5103) 5103
endocrinology & metabolism (3883) 3883
aged (3606) 3606
adult (3597) 3597
diabetic nephropathies (3585) 3585
diabetic nephropathies - drug therapy (3314) 3314
diabetic nephropathy (3115) 3115
risk factors (3076) 3076
rats (2889) 2889
diabetes mellitus (2831) 2831
diabetics (2731) 2731
type 2 diabetes (2728) 2728
urology & nephrology (2676) 2676
hypertension (2565) 2565
nephropathy (2538) 2538
research (2512) 2512
diabetes mellitus, type 2 - complications (2409) 2409
oxidative stress (2398) 2398
care and treatment (2293) 2293
mellitus (2114) 2114
diabetes mellitus, type 2 - drug therapy (1987) 1987
health aspects (1810) 1810
analysis (1792) 1792
glucose (1788) 1788
diabetic-nephropathy (1766) 1766
kidney diseases (1759) 1759
pharmacology & pharmacy (1715) 1715
diabetic nephropathies - physiopathology (1666) 1666
mice (1633) 1633
diabetic retinopathy (1613) 1613
treatment outcome (1543) 1543
mortality (1542) 1542
hypoglycemic agents - therapeutic use (1534) 1534
complications (1527) 1527
diabetic nephropathies - prevention & control (1519) 1519
angiotensin-converting enzyme inhibitors - therapeutic use (1513) 1513
blood pressure (1500) 1500
hypertension - drug therapy (1484) 1484
abridged index medicus (1457) 1457
disease (1452) 1452
medicine & public health (1435) 1435
insulin (1416) 1416
drug therapy (1397) 1397
medicine, general & internal (1372) 1372
diabetic nephropathies - metabolism (1355) 1355
proteinuria (1348) 1348
blood glucose - metabolism (1320) 1320
hyperglycemia (1302) 1302
rodents (1293) 1293
antihypertensive agents - therapeutic use (1285) 1285
kidney - drug effects (1283) 1283
disease progression (1276) 1276
development and progression (1236) 1236
inflammation (1226) 1226
medical research (1226) 1226
albuminuria (1207) 1207
diabetes therapy (1206) 1206
internal medicine (1186) 1186
blood-pressure (1159) 1159
risk (1145) 1145
progression (1137) 1137
diabetes mellitus, type 1 - complications (1132) 1132
diabetic nephropathies - complications (1132) 1132
nephrology (1131) 1131
diabetic nephropathies - etiology (1129) 1129
diabetic nephropathies - pathology (1123) 1123
time factors (1073) 1073
expression (1071) 1071
prevalence (1055) 1055
diabetes mellitus, experimental - drug therapy (1052) 1052
kidney - pathology (1051) 1051
diabetes mellitus, type 2 - blood (1038) 1038
medicine, research & experimental (1038) 1038
blood pressure - drug effects (1033) 1033
physiological aspects (1021) 1021
glomerular filtration rate (1017) 1017
complications and side effects (1011) 1011
chronic kidney failure (1004) 1004
medicine (1003) 1003
medicine, experimental (984) 984
microalbuminuria (982) 982
kidneys (981) 981
cardiovascular disease (970) 970
diabetes mellitus, type 1 - drug therapy (968) 968
diabetes mellitus, type 2 - physiopathology (967) 967
type 1 diabetes (950) 950
proteins (946) 946
rats, sprague-dawley (930) 930
studies (925) 925
peripheral vascular disease (913) 913
prevention (903) 903
insulin - therapeutic use (896) 896
research article (891) 891
kidney - metabolism (887) 887
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (89) 89
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Online Resources - Online (6) 6
Providence Healthcare - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Credit Valley Hospital - Stacks (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Toronto East General Hospital - Stacks (2) 2
Credit Valley Hospital - May be requested in 6-10 wks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Media Commons - Microtexts (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Trillium Health Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20268) 20268
German (239) 239
Chinese (136) 136
French (122) 122
Japanese (120) 120
Spanish (97) 97
Russian (64) 64
Italian (44) 44
Polish (31) 31
Hungarian (21) 21
Danish (18) 18
Czech (15) 15
Swedish (12) 12
Dutch (9) 9
Portuguese (9) 9
Korean (7) 7
Finnish (6) 6
Hebrew (4) 4
Romanian (4) 4
Bulgarian (3) 3
Serbian (3) 3
Turkish (3) 3
Ukrainian (3) 3
Croatian (2) 2
Norwegian (2) 2
Romansh (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 09/2015, Volume 314, Issue 9, pp. 884 - 894
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 20, pp. 1892 - 1903
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 839 - 848
In a randomized, controlled trial, liraglutide (a glucagon-like peptide 1 receptor agonist) or placebo was added to usual care in patients with type 2... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | ALBUMINURIA | INTENSIVE GLUCOSE CONTROL | KIDNEY-FUNCTION | DISEASE | RISK | DEATH | NEPHROPATHY | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Albuminuria - prevention & control | Acute Kidney Injury - prevention & control | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - prevention & control | Glucagon-Like Peptide 1 - agonists | Liraglutide - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Care and treatment | Usage | Analysis | Diabetic nephropathies | Outcome and process assessment (Health Care) | Research | Liraglutide | Myocardial infarction | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Glucagon | Diabetes mellitus | Patients | Risk factors | Clinical outcomes | Glomerular filtration rate | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Drug therapy | Glucagon-like peptide 1 | Long-term effects | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article